Organon & Co. (OGN)
Healthcare • Drug Manufacturers - General
StockNYSEUnited StatesUS68622V1061
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Organon & Co., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:18. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 08:00 | 0.69 | — | — | Upcoming |
| 30 Oct 2026 08:00 | 0.95 | 0.94 | -0.7% | In line |
| 31 Jul 2026 08:00 | 1.07 | 0.85 | -20.6% | Miss |
| 30 Apr 2026 07:00 | 0.85 | 0.71 | -16.8% | Miss |
| 12 Feb 2026 07:00 | 0.73 | 0.63 | -13.3% | Miss |
| 10 Nov 2025 07:00 | 0.93 | 1.01 | +8.5% | Beat |
| 05 Aug 2025 07:00 | 0.94 | 1.00 | +6.4% | Beat |
| 01 May 2025 07:00 | 0.89 | 1.02 | +14.2% | Beat |
| 13 Feb 2025 07:00 | 0.87 | 0.90 | +4.0% | Beat |
| 31 Oct 2024 07:00 | 0.90 | 0.87 | -3.7% | Miss |
| 06 Aug 2024 07:00 | 1.08 | 1.12 | +4.1% | Beat |
| 02 May 2024 07:00 | 0.93 | 1.22 | +30.6% | Beat |
| 15 Feb 2024 07:00 | 0.83 | 0.88 | +6.1% | Beat |
| 02 Nov 2023 07:00 | 1.06 | 0.87 | -17.6% | Miss |
| 08 Aug 2023 07:00 | 0.99 | 1.31 | +32.0% | Beat |
| 04 May 2023 07:00 | 1.16 | 1.08 | -7.2% | Miss |
| 16 Feb 2023 08:00 | 0.91 | 0.81 | -10.9% | Miss |
| 03 Nov 2022 07:00 | 1.10 | 1.32 | +20.1% | Beat |
| 04 Aug 2022 07:00 | 1.19 | 1.25 | +4.7% | Beat |
| 05 May 2022 07:00 | 1.30 | 1.65 | +26.7% | Beat |
| 17 Feb 2022 06:00 | 1.27 | 1.37 | +7.7% | Beat |
| 11 Nov 2021 06:00 | 1.44 | 1.67 | +15.9% | Beat |
| 12 Aug 2021 07:00 | 1.43 | 1.72 | +20.2% | Beat |
| 21 Jun 2021 08:00 | 1.57 | 1.56 | -0.3% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 6.2B | -2.9% | 187M | 3.0% | 0.72 | -78.4% | 384M |
| 2024 | 6.4B | +2.2% | 864M | 13.5% | 3.33 | -16.5% | 588M |
| 2023 | 6.3B | +1.4% | 1B | 16.3% | 3.99 | +11.1% | 538M |
| 2022 | 6.2B | — | 917M | 14.9% | 3.59 | — | 431M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 13.85 | 13.90 | 13.78 | 13.90 | +0.40% | 26,418,492 | 0.0200 |
| Oct 2026 | 13.71 | 13.84 | 13.70 | 13.84 | +1.02% | 49,576,600 | |
| Sep 2026 | 13.75 | 13.79 | 13.63 | 13.70 | -0.44% | 54,745,500 | |
| Aug 2026 | 13.57 | 13.77 | 13.54 | 13.76 | +1.55% | 60,688,200 | 0.0200 |
| Jul 2026 | 13.51 | 13.60 | 13.46 | 13.55 | +0.07% | 58,045,900 | |
| Jun 2026 | 13.37 | 13.56 | 13.35 | 13.54 | +1.50% | 51,285,800 | |
| May 2026 | 13.31 | 13.48 | 13.25 | 13.34 | +0.68% | 99,178,300 | 0.0200 |
| Apr 2026 | 5.97 | 13.39 | 5.82 | 13.25 | +121.20% | 374,566,400 | |
| Mar 2026 | 7.10 | 7.24 | 5.69 | 5.99 | -17.83% | 74,973,000 | |
| Feb 2026 | 8.53 | 8.53 | 6.50 | 7.29 | -14.64% | 92,362,300 | 0.0200 |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Organon Presents New Analysis of Pooled Post-Hoc Phase 3 Data on VTAMA® (tapinarof) cream, 1%, Demonstrating Consistent Efficacy in Atopic Dermatitis Across Diverse Patient Subgroups at ACAAI (opens in a new tab) 12 Nov 2026 15:00
- Reported Saturday, Organon Presents Real-World Data At ACR Showing 1.3% Switchback Rate After Over 16,000 US Veterans Switched From HUMIRA To HADLIMA (opens in a new tab) Benzinga · 09 Nov 2026 04:46
- New Real-World Evidence Presented by Organon at the American College of Rheumatology (ACR) Annual Meeting Evaluated a Large-Scale Switch to HADLIMA® (adalimumab-bwwd) Across United States Veterans Affairs Healthcare System (opens in a new tab) 07 Nov 2026 15:00
- Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1% at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting (opens in a new tab) 05 Nov 2026 13:00
- Organon To Present New Analysis Of Phase 3 Data Evaluating VTAMA Cream In Patients With Atopic Dermatitis, At 2026 ACAAI Annual Scientific Meeting (opens in a new tab) Benzinga · 05 Nov 2026 09:01
- Organon (OGN) Q3 Results Highlight A Thin Margin Cushion (opens in a new tab) Simply Wall St. · 01 Nov 2026 05:10
- Organon (OGN) Q3 Earnings and Revenues Top Estimates (opens in a new tab) Zacks · 30 Oct 2026 12:30
- Organon: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 30 Oct 2026 12:26
- Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (opens in a new tab) Zacks · 26 Oct 2026 12:00
- Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (opens in a new tab) Zacks · 14 Oct 2026 13:00
- Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (opens in a new tab) Zacks · 02 Oct 2026 13:00
- Why Organon (OGN) Is Getting Attention Today (opens in a new tab) Simply Wall St. · 22 Sep 2026 13:15
- Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device (opens in a new tab) Simply Wall St. · 22 Sep 2026 04:24
- Is Trending Stock Organon & Co. (OGN) a Buy Now? (opens in a new tab) Zacks · 21 Sep 2026 14:00
- Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (opens in a new tab) Zacks · 08 Sep 2026 14:00
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 13.90 USD
- Market cap
- 3.7B
- Dividend yield
- 0.58%
- 5-year average yield
- 2.44%
- Payout ratio
- 10%
- Last dividend
- 0.0200 USD · 09 Nov 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 09 Nov 2026 | 0.0200 USD |
| 14 Aug 2026 | 0.0200 USD |
| 11 May 2026 | 0.0200 USD |
| 23 Feb 2026 | 0.0200 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow OGN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.